IOVS Journal of Pharmacology and Experimental Therapeutics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2007;48:5377-5387.)
© 2007 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.07-0673

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ruiz, A.
Right arrow Articles by Bok, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ruiz, A.
Right arrow Articles by Bok, D.

Somatic Ablation of the Lrat Gene in the Mouse Retinal Pigment Epithelium Drastically Reduces Its Retinoid Storage

Alberto Ruiz,1,2 Norbert B. Ghyselinck,3,4,5 Nathan Mata,6 Steven Nusinowitz,1 Marcia Lloyd,1 Christine Dennefeld,3 Pierre Chambon,3,4,5 and Dean Bok1,2,7

1From the Jules Stein Eye Institute, the 2Department of Neurobiology, and the 7Brain Research Institute, David Geffen School of Medicine, University of California, Los Angeles, California; 3IGBMC (Institut de Génétique et de Biologie Moléculaire et Cellulaire), 4INSERM (National Institute of Health and Medical Research), U596, CNRS (Centre National de la Recherche Scientifique), Illkirch, France; 5Université Louis Pasteur, Strasbourg, France; and 6Sirion Therapeutics, La Jolla, California.

PURPOSE. To generate a mouse model in which the Lrat gene is selectively disrupted in the retinal pigment epithelium (RPE). To evaluate the effects on the synthesis of retinyl esters and on the expression of other proteins involved in the continuation of the visual cycle.

METHODS. A mouse line in which part of the first exon of the Lrat gene has been flanked by loxP sites, was generated and used in the study (LratL3/L3 mice). Heterozygous mice (Lrat+/L3) were crossed with mice expressing Cre-recombinase under control of the tyrosinase-related protein-1 (Tyrp1) promoter, which is active selectively in melanin-synthesizing cells such as RPE cells. Accordingly, mice obtained from these crosses should display an RPE-specific disruption of the Lrat gene (Lratrpe–/–). In addition, by crossing CMV-Cre transgenic mice with LratL3/L3 animals, a germline null Lrat knockout (LratL–/L– mice) was generated. RNA and protein expression, endogenous retinoid levels, and electroretinogram (ERG) analyses were performed on Lratrpe–/– and LratL–/L– mice, to determine the effects of Lrat disruption. Retinoid levels in nonocular tissues were also analyzed for comparison.

RESULTS. Analysis of RPE tissues from Lratrpe–/– mice showed absence of Lrat message, lack of Lrat protein expression and consequently a reduced light response in ERG recordings. In addition, RPE cells from Lratrpe–/– showed a strong reduction in their ability to synthesize all-trans retinyl esters, whereas Lrat activity in other tissues known to process retinol was comparable to control LratL3/L3 animals. The LratL–/L– mice showed no detectable Lrat message, lack of protein expression, and barely detectable ester formation in RPE cells or several other relevant tissues analyzed.

CONCLUSIONS. Three Lrat mouse lines with genetic modifications were generated. The LratL–/L– mice displayed features similar to equivalent models previously reported by others. The second mouse line (Lratrpe–/–) displayed loss of Lrat function only in the RPE. The third line possesses functional Lrat in all tissues, but part of the Lrat coding gene was flanked by loxP sites (LratL3/L3). This feature allows the disruption of this gene in any tissue of choice, by intercrossing with mice in which Cre-recombinase expression is driven by an appropriate tissue-specific promoter.








HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the Association for Research in Vision and Ophthalmology